Program

Download a pdf of the scientific program

Thursday, October 22, 2015
	Hall A
17:45-18:00	Congress Opening
18:00-19:30	Plenary Session 1: Controversies in neoadjuvant chemotherapy
19:30	Networking Reception

Friday, October 23, 2015
	Hall A	Hall B
08:30-10:00	Parallel Session 2: Industry Symposium: Controversies in bone health Supported by Amgen Oncology Session not included in main CME/CPD program For more information click here	Parallel Session 3: Controversies in screening and imaging
10:00-10:30	*Coffee Break and Poster Viewing*
10:30-11:30	Parallel Session 4: Molecular profiling in early breast cancer: An important addition, or is a good pathologist enough?	Parallel Session 5: Free Communication Session
11:30-13:00	Parallel Session 6: Industry Symposium: Controversies in HER2-positive disease Supported by Roche Oncology Session not included in main CME/CPD program For more information click here	Parallel Session 7: Breast Care Nurses: Care coordinators or agents of lifestyle change?
13:00-14:00	*Lunch Break and Poster Viewing*
14:00-15:30	Parallel Session 8: Controversies in adjuvant chemotherapy	Parallel Session 9: Controversies in breast conservation: Better surgery, better pathology, better radiotherapy?
15:30-16:00	*Coffee Break and Poster Viewing*
16:00-17:30	Plenary Session 10: Controversies in loco-regional management

Saturday, October 24, 2015
	Hall A	Hall B
07:00-08:30	Plenary Session 11: Industry Breakfast Symposium: IORT for early breast cancer: From clinical trials to clinical reality Supported by ZEISS Session not included in main CME/CPD program For more information click here
08:30-10:00	Plenary Session 12: Controversies in adjuvant endocrine therapy
10:00-10:30	*Coffee Break and Poster Viewing*
10:30-11:30	Parallel Session 13: Controversies in brain metastases	Parallel Session 14: Controversies in DCIS: Should all cases be treated?
11:30-13:00	Parallel Session 15: Industry Symposium: Management of endocrine resistance Supported by Novartis Oncology Session not included in main CME/CPD program For more information click here	Parallel Session 16: Who is responsible for follow-up and survivorship care of women with early stage breast cancer?
13:00-14:30	*Lunch break and poster viewing*
13:30-14:20	Case Discussion Panel
14:30-15:30	Parallel Session 17: Controversies in breast reconstruction	Parallel Session 18: Controversies in advanced breast cancer
15:35-16:50	Plenary Session 19: Breast cancer 2020
16:50-17:00	Congress closing and award presentation

*In order to view the full session program, please press on the session link